The transaction that involved 3.21 million shares was carried on the regulated market of the Bucharest Stock Exchange at a median price of 0.6979 lei/share.

Sanofi-Aventis’ interest is now at 79.08% after in the public offering carried in August 12 - September 22, the drug company bought only 3.4% of Zentiva.

The drug maker reported profit of 3.21 million lei (€0.76 million), for the first nine months, 7 times lower compared to the same period of last year, which indicates a 5.33 million lei loss for the third quarter.

Zentiva has a share capital of 41.69 million lei, divided into 416.9 million shares at a face value of 0.1 lei.

The market value is 291.87 million (€67.9 million), according to Friday’s closing quote of 0.7lei/share.